{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:18Z","timestamp":1707525378377},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.7759\/cureus.47076","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:29:26Z","timestamp":1697405366000},"source":"Crossref","is-referenced-by-count":0,"title":["Anesthetic Management for a Child With a Newly Identified Mitochondrial Disease SLC25A46 Mutation: A Case Report"],"prefix":"10.7759","author":[{"given":"Thong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Shabot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Yngve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Abouleish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26716","article-title":"SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy","volume":"31","author":"Charlesworth G","year":"2016","unstructured":"Charlesworth G, Balint B, Mencacci NE, Carr L, Wood NW, Bhatia KP. SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy. Mov Disord. 2016, 31:1249-51. 10.1002\/mds.26716","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12774","article-title":"Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder","volume":"91","author":"Nguyen M","year":"2017","unstructured":"Nguyen M, Boesten I, Hellebrekers DM, Mulder-den Hartog NM, de Coo IF, Smeets HJ, Gerards M. Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder. Clin Genet. 2017, 91:121-5. 10.1111\/cge.12774","journal-title":"Clin Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww212","article-title":"Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia","volume":"139","author":"Wan J","year":"2016","unstructured":"Wan J, Steffen J, Yourshaw M, et al.. Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia. Brain. 2016, 139:2877-90. 10.1093\/brain\/aww212","journal-title":"Brain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx262","article-title":"Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice","volume":"26","author":"Li Z","year":"2017","unstructured":"Li Z, Peng Y, Hufnagel RB, et al.. Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice. Hum Mol Genet. 2017, 26:3776-91. 10.1093\/hmg\/ddx262","journal-title":"Hum Mol Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23639","article-title":"Insights into the genotype-phenotype correlation and molecular function of SLC25A46","volume":"39","author":"Abrams AJ","year":"2018","unstructured":"Abrams AJ, Fontanesi F, Tan NB, et al.. Insights into the genotype-phenotype correlation and molecular function of SLC25A46. Hum Mutat. 2018, 39:1995-2007. 10.1002\/humu.23639","journal-title":"Hum Mutat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12158","article-title":"Anesthetic considerations in patients with mitochondrial defects","volume":"23","author":"Niezgoda J","year":"2013","unstructured":"Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth. 2013, 23:785-93. 10.1111\/pan.12158","journal-title":"Paediatr Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2006.00988.x","article-title":"Volatile anaesthetics depolarize neural mitochondria by inhibiton of the electron transport chain","volume":"50","author":"Bains R","year":"2006","unstructured":"Bains R, Moe MC, Larsen GA, Berg-Johnsen J, Vinje ML. Volatile anaesthetics depolarize neural mitochondria by inhibiton of the electron transport chain. Acta Anaesthesiol Scand. 2006, 50:572-9. 10.1111\/j.1399-6576.2006.00988.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2002.025015","article-title":"Halothane, isoflurane and sevoflurane inhibit NADH: ubiquinone oxidoreductase (complex I) of cardiac mitochondria","volume":"544","author":"Hanley PJ","year":"2002","unstructured":"Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH: ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 2002, 544:687-93. 10.1113\/jphysiol.2002.025015","journal-title":"J Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2006.02043.x","article-title":"Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects","volume":"17","author":"Driessen J","year":"2007","unstructured":"Driessen J, Willems S, Dercksen S, Giele J, van der Staak F, Smeitink J. Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Paediatr Anaesth. 2007, 17:16-21. 10.1111\/j.1460-9592.2006.02043.x","journal-title":"Paediatr Anaesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200610000-00029","article-title":"Clinical implications of mitochondrial dysfunction","volume":"105","author":"Muravchick S","year":"2006","unstructured":"Muravchick S, Levy RJ. Clinical implications of mitochondrial dysfunction. Anesthesiology. 2006, 105:819-37. 10.1097\/00000542-200610000-00029","journal-title":"Anesthesiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000484","article-title":"Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q","volume":"122","author":"Vanlander AV","year":"2015","unstructured":"Vanlander AV, Okun JG, de Jaeger A, et al.. Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q. Anesthesiology. 2015, 122:343-52. 10.1097\/ALN.0000000000000484","journal-title":"Anesthesiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0883073813498640","article-title":"Effect of a single dose of propofol and lack of dextrose administration in a child with mitochondrial disease: a case report","volume":"29","author":"Mtaweh H","year":"2014","unstructured":"Mtaweh H, Bay\u0131r H, Kochanek PM, Bell MJ. Effect of a single dose of propofol and lack of dextrose administration in a child with mitochondrial disease: a case report. J Child Neurol. 2014, 29:40-6. 10.1177\/0883073813498640","journal-title":"J Child Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128445","article-title":"Ketamine causes mitochondrial dysfunction in human induced pluripotent stem cell-derived neurons","volume":"10","author":"Ito H","year":"2015","unstructured":"Ito H, Uchida T, Makita K. Ketamine causes mitochondrial dysfunction in human induced pluripotent stem cell-derived neurons. PLoS One. 2015, 10:e0128445. 10.1371\/journal.pone.0128445","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2017.09.014","article-title":"Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson's disease","volume":"10","author":"Fan JC","year":"2017","unstructured":"Fan JC, Song JJ, Wang Y, Chen Y, Hong DX. Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson's disease. Asian Pac J Trop Med. 2017, 10:1007-10. 10.1016\/j.apjtm.2017.09.014","journal-title":"Asian Pac J Trop Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.182085","article-title":"Intravenous sub-anesthetic ketamine for perioperative analgesia","volume":"32","author":"Gorlin AW","year":"2016","unstructured":"Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol. 2016, 32:160-7. 10.4103\/0970-9185.182085","journal-title":"J Anaesthesiol Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/195182-anesthetic-management-for-a-child-with-a-newly-identified-mitochondrial-disease-slc25a46-mutation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:39Z","timestamp":1707509139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/195182-anesthetic-management-for-a-child-with-a-newly-identified-mitochondrial-disease-slc25a46-mutation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.47076","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,15]]}}}